Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
1997

Elevated Angiogenic Cytokines in Cancer Patients

Sample size: 146 publication Evidence: moderate

Author Information

Author(s): LY Dirix, PB Vermeulen, A Pawinski, A Prov63, I Benoy, C De Pooter, M Martin, AT Van Oosterom

Primary Institution: Catholic University of Leuven

Hypothesis

The study investigates the association of serum bFGF and VEGF levels with clinical parameters of disease progression in metastatic cancer patients.

Conclusion

The study found that elevated serum levels of bFGF and VEGF are associated with disease progression in cancer patients.

Supporting Evidence

  • 57% of untreated patients had elevated serum levels of one or both angiogenic factors.
  • 58% of patients with progressive disease had elevated bFGF and/or VEGF levels compared to 15% of responding patients.
  • Two-thirds of patients with progressive disease had increasing serum levels of angiogenic factors.

Takeaway

Doctors found that many cancer patients have higher levels of certain proteins in their blood that help tumors grow. This could help them understand how fast the cancer is getting worse.

Methodology

Serum samples were taken from 146 patients and analyzed for bFGF and VEGF levels using ELISA.

Limitations

The study may not account for all factors influencing angiogenic factor levels, and the sample size may limit generalizability.

Participant Demographics

Patients included 90 untreated and 42 treated metastatic cancer patients with various tumor types.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication